MGLL and cancer: Monoacylglycerol lipase is a major enzyme involved in triglyceride degradation and arachidonic acid synthesis in particular tissues and has been considered a promising therapeutic target for treating diverse disorders, including autoimmune, cancer, neurodegenerative, and inflammatory diseases (Nomura et al., 2010; Jiang et al., 2015; Zhu et al., 2016; Pasquarelli et al., 2017).